CARDIUM THERAPEUTICS

cardium-therapeutics-logo

Cardium is focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses that have the potential to address significant unmet medical needs and definable pathways to partnering, commercialization and other economic monetizations. Cardium's investment portfolio includes the Tissue Repair Company and Cardium Biologics, medical technology companies primarily focused on the development of innovative therapeutic products for wound healing and cardiovascular indications, and the To Go Brands nutraceutical supplement business.

#SimilarOrganizations #People #Financial #Website #More

CARDIUM THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical Therapeutics

Founded:
2003-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.cardiumthx.com

Total Employee:
11+

Status:
Active

Contact:
8584361001

Email Addresses:
[email protected]

Total Funding:
750 K USD

Technology used in webpage:
Domain Not Resolving Google Maps


Similar Organizations

origin-logo

Origin

Origin is a privately held, clinical-stage biotechnology company.

albumedix-logo

Albumedix

Albumedix is a science-driven, biotechnology company

aten-therapeutics-logo

Aten Therapeutics

Aten Therapeutics is an innovative biotechnology company

califia-bio-logo

Califia Bio

Califia Bioโ€™s expertise is in hit generation, lead optimization and preclinical development.

cognigen-logo

Cognigen

Since opening our doors in 1992, weโ€™ve partnered with leading pharmaceutical and biotechnology companies

akashi-therapeutics-logo

Akashi Therapeutics

Akashi Therapeutics is a clinical stage biopharmaceutical company.

ekr-therapeutics-logo

EKR Therapeutics

EKR Therapeutics provides a segment of the healthcare market with products to improve patient outcomes and quality of life.

elfamed-logo

Elfamed

Elfamed is a regenerative medicine and biotechnology company

factor-therapeutics-ltd-logo

Factor Therapeutics Ltd.

Factor Therapeutics Ltd. is an Australian biotechnology company

healshape-logo

Healshape

Healshape is a 3D bioprinting regenerative medecine company.

not_available_image

Heart Health

Heart Health is a company focused on biotechnology.

january-therapeutics-logo

January Therapeutics

January Therapeutics is a San Diego-based biotechnology company.

not_available_image

Ontario Institute For Regenerative Medicine

Ontario Institute For Regenerative Medicine is a biotechnology emergency medicine company.

recyte-therapeutics-logo

ReCyte Therapeutics

ReCyte Therapeutics is a regenerative medicine company focused on stem cell technology.

scistem-therapeutics-logo

SciStem Therapeutics

SciStem Therapeutics is an early stage regenerative medicine company.


Current Advisors List

andrew-leitch_image

Andrew Leitch Member of the Board of Directors @ Cardium Therapeutics
Board_member
2007-08-01

Founder


not_available_image

Chris Reinhard

Stock Details


Company's stock symbol is OTCPINK:CRXM

Acquisitions List

Date Company Article Price
2006-08-11 Tissue Repair Company Tissue Repair Company acquired by Cardium Therapeutics N/A
2006-03-09 INNERCOOL Therapies INNERCOOL Therapies acquired by Cardium Therapeutics N/A

Official Site Inspections

http://www.cardiumthx.com

  • Host name: 172.67.166.205
  • IP address: 172.67.166.205
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Cardium Therapeutics"

Cardium Therapeutics - Crunchbase Company Profile

Contact Email [email protected] Phone Number 8584361001 Cardium is focused on the acquisition and strategic development of new and โ€ฆSee details»

CARDIUMTHERAPEUTICS - PTCA

To the World Health Organization, by 2020 heart disease and stroke will become the leading causes of both death and disability worldwide, with the number of fatalities projected to โ€ฆSee details»

Cardium Therapeutics, Inc. | LinkedIn

Cardium Therapeutics, Inc. | 435 followers on LinkedIn. Cardium Therapeutics is focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and ...See details»

Cardium Therapeutics, Inc. Overview | SignalHire Company Profile

Organization Website: cardiumthx.com : Contact Email: [email protected]: Cardium Therapeutics... industries Biotech: Headquarters Location: 12255 El Camino Real, โ€ฆSee details»

Cardium Therapeutics Inc., Christopher J. Reinhard,

[email protected]: Phone: 1-858-436-1000: Website: www.cardiumthx.com Fax: 1-858-436-1001: Summary ; Executive Details ; Financial Details ; Board Members ; Stock โ€ฆSee details»

Cardium Therapeutics Inc. - SlideShare

Cardium Therapeuitcs (NYSE MKT: CXM) is focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses that โ€ฆSee details»

Cardium Therapeutics - VentureRadar

Cardium Therapeutics VentureRadar profile. Find out more about Cardium Therapeutics, Stem Cells, DNA, RNA and Peptide Therapies.See details»

Cardium Therapeutics (CXM) Corporate Profile | OTC โ€ฆ

Cardium Therapeutics Website Get connected with Cardium Therapeutics. Request More CXM Information View all articles and comment in the CXM blog. About Cardium Therapeutics. Cardium is a health sciences and regenerative โ€ฆSee details»

Cardium Becomes Taxus Cardium Pharmaceuticals Group In โ€ฆ

SAN DIEGO, March 17, 2014 /PRNewswire/ -- Cardium Therapeutics Inc. (Trading Symbol: CRXM) reported that it has changed its corporate name and business to Taxus Cardium โ€ฆSee details»

Tissue Repair Company - Crunchbase Company Profile & Funding

Organization. Tissue Repair Company . Connect to CRM . Save . Summary. People. Technology. Signals & News. ... Contact Email [email protected]; Phone Number (858) โ€ฆSee details»

Cardium Therapeutics, Inc. (CXM) and the Generx Strategy

Feb 20, 2013 Cardium Therapeuticsโ€™ lead clinical development product candidate is Generx, a DNA-based angiogenic growth factor therapeutic being developed for the potential treatment โ€ฆSee details»

Cardium Announces Positive Interim Phase 3 Clinical Data โ€ฆ

SAN DIEGO, June 24, 2014 /PRNewswire/ -- Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM) will report today at the Biotechnology Industry Organization's 2014 โ€ฆSee details»

Cardium Therapeutics, Inc.โ€™s (CXM) Generx® Addresses Global โ€ฆ

Oct 25, 2013 Among other opportunities in its portfolio, the companyโ€™s lead clinical development product candidate, Generx®, is being developed to treat patients with advanced coronary โ€ฆSee details»

Cardium Therapeutics, Inc. And Aries Ventures Announce Merger ...

Oct 20, 2005 Cardium Therapeutics, Inc. And Aries Ventures Announce Merger, Completion Of $30 Million Financing And Strategic Acquisition Of Cardiovascular Product Portfolio - read this โ€ฆSee details»

Articles about Cardium Therapeutics, Inc. - BioSpace

Jun 12, 2014 Cardium Therapeutics, Inc. To Announce Interim Results Of Generx Angiogenic Gene Therapy Phase 3 Clinical Study At The 2014 Biotechnology Industry Organization (BIO) โ€ฆSee details»

Cardium's Generx Advances to Phase 3 Following Meeting with FDA

SAN DIEGO, CA โ€“ December 7, 2006 โ€“ Cardium Therapeutics, Inc (OTCBB: CDTP) announced that Generxโ„ข (alferminogene tadenovec) is to be advanced to a Phase 3 clinical trial in โ€ฆSee details»

www.Cardiumthx.com - Cardium Therapeutics, Innovative Bio

In the United States, Cardiumthx.com is ranked 258,584, with an estimated 3,962 monthly visitors a month. Click to view other data about this site. Cardiumthx.com. Go to website. Cardiumthx โ€ฆSee details»

Cardium Announces Strategic Collaboration And Funding With โ€ฆ

SAN DIEGO, March 3, 2014 /PRNewswire/ -- Cardium Therapeutics Inc. (Trading Symbol: CRXM) reported that it has entered into a strategic collaboration and funding arrangement with โ€ฆSee details»

Cardium Therapeutics, Inc. Provides Updated Summary Of

Apr 4, 2006 Cardium Therapeutics, Inc. Provides Updated Summary Of Generx Clinical Program For Potential Treatment Of Coronary Heart Disease - read this article along with other careers โ€ฆSee details»

Cardium Announces Strategic Focus On Advanced Regenerative โ€ฆ

SAN DIEGO, Jan. 27, 2014 /PRNewswire/ -- Cardium Therapeutics Inc. (Ticker Symbol: CRXM) reported on the Company's strategic focus on its two advanced regenerative medicine โ€ฆSee details»

linkstock.net © 2022. All rights reserved